Sensor-augmented Pump Versus Multiple Daily Injections With Degludec as Basal Insulin for Insulin Therapy in Type 1 Diabetes

NCT03557892 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

DEVICE: CGM+CSII
DEVICE: MDI with degludec

Sponsor

Azienda Ospedaliero-Universitaria Careggi